Estradiol Patch Brands: Climara, Vivelle-Dot, Minivelle and Generics

The main practical split. Climara and its generics are changed once a week. Vivelle-Dot, Minivelle and their generics are changed twice a week, on the same two days.

Neither is better on the hormone. The weekly patch holds a seven-day supply and is larger for it; the twice-weekly patch is smaller and thinner. Some women prefer one fewer thing to remember; others find a smaller patch stays on better and is less visible. A woman whose skin reacts to adhesive may do better with a smaller patch and more frequent rotation. It is a preference and a skin question, not a clinical one.

All current patches are matrix patches — the estradiol is dissolved in the adhesive layer itself — which replaced the older reservoir design that could leak if cut. Matrix patches are thin, flexible and, within limits, tolerant of being trimmed, though no manufacturer recommends it.

Adhesion is where the brands genuinely differ, and where generics can differ from the brand they copy. The drug is the same; the adhesive formulation is proprietary, and a generic that delivers identical estradiol can still lift at the edges sooner, leave more residue, or irritate more. Skin irritation is the commonest reason women stop a patch, and often the fix is a different product rather than a different route.

The main page's FAQ covers what to do if a patch falls off. The short version: it happens, it is not an emergency, and a pattern of it is a reason to try another brand.

Generic estradiol patches are approved on bioequivalence — they deliver the same estradiol at the same rate as the reference product — and on that measure they are interchangeable. The FDA rates most of them AB, meaning a pharmacist may substitute without calling the prescriber.

What bioequivalence does not test is the adhesive, the size, or how the patch behaves on a given woman's skin in a given climate. A woman stable on one product who is switched by her pharmacy to another and finds it falls off or irritates is not imagining the difference; she is experiencing the part the equivalence rating does not measure. The prescriber can write "dispense as written" to hold a product, and we will, where there is a reason.

For a new prescription we have no default brand, because the right answer is the one that stays on your skin and fits your week. What we do have is a rule: if the first product irritates, lifts or falls off more than occasionally in the first month, the next step is a different patch, not a return to a pill. The route is worth keeping; the product is worth changing.